Archer Investment Corporation’s SIMCERE PHARMACEUTICAL GROUP, ADS SCR Stock Holding History

Archer Investment Corporation’s Portfolio SCR Stock Details SCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,000	Closed	-$26.9K	–	778
2021 Q1	$26.9K	Buy	+1,000	New	+$26.9K	0.01%	431

Archer Investment Corporation's SCR Position: Q2 2021 in Review

Archer Investment Corporation sold out of SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) in Q2 2021, closing a stake of 1,000 shares — an estimated $26.9K sold.

Archer Investment Corporation first reported a position in SCR in Q1 2021 and held it in 1 quarter. The position peaked at $26.9K in Q1 2021. 0 funds tracked by Wall St. Rank hold SCR as of Q2 2021.

Archer Investment Corporation reported no remaining SIMCERE PHARMACEUTICAL GROUP, ADS position as of Q2 2021 after selling out during the quarter.
Archer Investment Corporation sold 1,000 SIMCERE PHARMACEUTICAL GROUP, ADS shares in Q2 2021, an estimated $26.9K.
Archer Investment Corporation first reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS in Q1 2021 and held it in 1 quarter.
Archer Investment Corporation's SIMCERE PHARMACEUTICAL GROUP, ADS position peaked at $26.9K in Q1 2021.
0 funds tracked by Wall St. Rank held SIMCERE PHARMACEUTICAL GROUP, ADS as of Q2 2021.

Based on Archer Investment Corporation's 13F filing for Q2 2021, filed 5 Aug 2021.